All trials - page: 256

All trials

Displaying of results
Download as CSV
NCTID
Brief title
Sponsor
Design
Criteria
Status
Target enrollment
Study phase & design
Primary intervention type
Primary potential benefit
Outcome measure
Follow up
Start date
First posted
Location
NCT02031835Body Weight Supported Treadmill Training as Physical Therapy Treatment to Spinal Cord Injury PatientsUniversity of Ioannina
  • Age 8 - 88 yrs
  • Level C5-T12
  • AIS B, C, D
  • ≤ 88 years
Ended26NARehabilitationStanding/walking/mobility01 March 201209 January 20141
NCT01923662A Neuroprosthesis for Prolonged Standing After SCI Using Multi-Contact Peripheral Nerve ElectrodesVA Office of Research and Development
  • Age ≥ 21 yrs
  • Level C6-T12
  • AIS A, B, C, D
  • ≥ 6 months
  • be capable of moving hip, knee and ankle joints through normal range of motion
Ended6NATechnologyStanding/walking/mobility11 April 201315 August 20131
NCT01894802Cortical Recording and Stimulating Array Brain-Machine InterfaceUniversity of Pittsburgh
  • Age 22 - 70 yrs
  • Level C1-C5
  • AIS A, B, C, D
  • 1 years - 70 years
  • have limited or no ability to use both hands.
  • have no other implanted electrical device (e.g. pacemaker, cochlear implants).
Recruiting30NATechnologyArm/hand function01 December 201310 July 20132
NCT01772810Safety Study of Human Spinal Cord-derived Neural Stem Cell Transplantation for the Treatment of Chronic SCINeuralstem Inc.
  • Age 18 - 65 yrs
  • Level C5-C7
  • AIS A
  • 1 years - 2 years
  • live within 500 miles from University of California San Diego Medical Center
  • NOT have penetrating injury, e.g. gunshot or knife wound
  • NOT have received investigational drug or device within 30 days of stem cell operation
  • NOT have implanted spine stimulator
8PHASE1Biological/cell basedStanding/walking/mobility01 August 201421 January 20131
NCT01714349Nerve Transfer After Spinal Cord InjuriesWashington University School of Medicine
  • Age 18 - 65 yrs
  • Level C1-C8
  • AIS A, B, C
  • 6 months - 48 months
  • have no significant pain
  • show minimal or no evidence of motor function improvement after 6 months post-injury
Ended20NASurgeryArm/hand function01 October 201225 October 20122
NCT01676441Safety and Efficacy of Autologous Mesenchymal Stem Cells in Chronic Spinal Cord InjuryPharmicell Co., Ltd.
  • Age 16 - 65 yrs
  • Level C1-C8
  • AIS B
  • 12 months - 65 years
  • NOT have undergone major surgery in past 3 months
  • NOT be dependent on mechanical ventilator
  • NOT have penetrating injury, e.g. gunshot or stab wound
  • NOT have other implanted device, e.g. pacemaker
Ended20PHASE2, PHASE3Biological/cell basedGeneral health01 August 200831 August 20122